The DOI matches its Crossref record; 272 of the 272 references it cites were found in a registry or an index.
Engineering nanomedicine for glutathione depletion-augmented cancer therapy
Abstract
In this review, we systematically survey the most recent progress in engineering nanomedicine for intracellular glutathione consumption-augmented cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Oncology meets immunology: the cancer-immunity cycle.
Chen, D. S., & Mellman, I. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.012 · Cited by 6,929
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Meister, A., & Anderson, M. E. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.003431 · Cited by 5,680
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Vermorken, J. B., Mesia, R., Rivera, F., Remenar, E., Kawecki, A., Rottey, S., Erfan, J., Zabolotnyy, D., Kienzer, H.-R., Cupissol, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802656 · Cited by 3,726
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Clinical development and potential of photothermal and photodynamic therapies for cancer
Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
Mok, T. S., Wu, Y.-L., Ahn, M.-J., Garassino, M. C., Kim, H. R., Ramalingam, S. S., Shepherd, F. A., He, Y., Akamatsu, H., Theelen, W. S. M. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612674 · Cited by 3,379
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Ferroptosis: Death by Lipid Peroxidation
Yang, W. S., & Stockwell, B. R. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.014 · Cited by 3,088
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Glutathione: overview of its protective roles, measurement, and biosynthesis
Forman, H. J., Zhang, H., & Rinna, A. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.006 · Cited by 2,636
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Lu, S. C. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.09.008 · Cited by 2,166
Ferroptosis: machinery and regulation
Chen, X., Li, J., Kang, R., Klionsky, D. J., & Tang, D. (2021) · Autophagy · doi:10.1080/15548627.2020.1810918 · Cited by 2,099
Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
Tang, Z., Liu, Y., He, M., & Bu, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201805664 · Cited by 1,951
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
Glutathione and its role in cellular functions
Sies, H. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00177-x · Cited by 1,735
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Beyond oxidative stress: an immunologist's guide to reactive oxygen species
Nathan, C., & Cunningham-Bussel, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3423 · Cited by 1,619
Cao, J. Y., & Dixon, S. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2194-1 · Cited by 1,515
Lin, L., Song, J., Song, L., Ke, K., Liu, Y., Zhou, Z., Shen, Z., Li, J., Yang, Z., Tang, W., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712027 · Cited by 1,466
The role of glutathione-S-transferase in anti-cancer drug resistance
Townsend, D. M., & Tew, K. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206940 · Cited by 1,353
Cysteine depletion induces pancreatic tumor ferroptosis in mice
Badgley, M. A., Kremer, D. M., Maurer, H. C., DelGiorno, K. E., Lee, H.-J., Purohit, V., Sagalovskiy, I. R., Ma, A., Kapilian, J., Firl, C. E. M., et al. (2020) · Science · doi:10.1126/science.aaw9872 · Cited by 1,294
Glutathione metabolism in cancer progression and treatment resistance
Bansal, A., & Simon, M. C. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201804161 · Cited by 1,233
Ma, B., Wang, S., Liu, F., Zhang, S., Duan, J., Li, Z., Kong, Y., Sang, Y., Liu, H., Bu, W., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08714 · Cited by 1,222
Self-citationRole of Glutathione in Cancer Progression and Chemoresistance
Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A., Marinari, U. M., & Domenicotti, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/972913 · Cited by 1,208
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., Zhang, Q., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.350 · Cited by 1,204
Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.038 · Cited by 1,192
ROS homeostasis and metabolism: a dangerous liason in cancer cells
Panieri, E., & Santoro, M. M. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.105 · Cited by 1,151
Reduction-sensitive polymers and bioconjugates for biomedical applications
Meng, F., Hennink, W. E., & Zhong, Z. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.026 · Cited by 1,131
Synthesis of Copper Peroxide Nanodots for H2O2 Self-Supplying Chemodynamic Therapy
Lin, L.-S., Huang, T., Song, J., Ou, X.-Y., Wang, Z., Deng, H., Tian, R., Liu, Y., Wang, J.-F., Liu, Y., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b03457 · Cited by 1,129
Glutathione in Cancer Biology and Therapy
Estrela, J. M., Ortega, A., & Obrador, E. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500523878 · Cited by 1,041
Kobayashi, H., Watanabe, R., & Choyke, P. L. (2014) · Theranostics · doi:10.7150/thno.7193 · Cited by 996
Harris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K. C., Yung, K. Y., Brenner, D., Knobbe-Thomsen, C. B., Cox, M. A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.019 · Cited by 993
Lewerenz, J., Hewett, S. J., Huang, Y., Lambros, M., Gout, P. W., Kalivas, P. W., Massie, A., Smolders, I., Methner, A., Pergande, M., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4391 · Cited by 978
Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals
Prasad, S., Gupta, S. C., & Tyagi, A. K. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.03.042 · Cited by 978
The role of glutathione in cancer
Balendiran, G. K., Dabur, R., & Fraser, D. (2004) · Cell Biochemistry and Function · doi:10.1002/cbf.1149 · Cited by 927
Godwin, A. K., Meister, A., O'Dwyer, P. J., Huang, C. S., Hamilton, T. C., & Anderson, M. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3070 · Cited by 925
Glutathione: an overview of biosynthesis and modulation
Anderson, M. E. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00146-4 · Cited by 917
Meister, A. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90076-x · Cited by 907
Reactive oxygen species and cancer paradox: To promote or to suppress?
Galadari, S., Rahman, A., Pallichankandy, S., & Thayyullathil, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.004 · Cited by 893
Qian, X., Zheng, Y., & Chen, Y. (2016) · Advanced Materials · doi:10.1002/adma.201602012 · Cited by 882
Role of Glutathione in Cancer: From Mechanisms to Therapies
Kennedy, L., Sandhu, J. K., Harper, M.-E., & Cuperlovic-Culf, M. (2020) · Biomolecules · doi:10.3390/biom10101429 · Cited by 880
Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements
Her, S., Jaffray, D. A., & Allen, C. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.012 · Cited by 865
Macromolecular therapeutics in cancer treatment: The EPR effect and beyond
Maeda, H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.038 · Cited by 814
Strategies for advancing cancer nanomedicine
Chauhan, V. P., & Jain, R. K. (2013) · Nature Materials · doi:10.1038/nmat3792 · Cited by 812
ATF3 promotes erastin-induced ferroptosis by suppressing system Xc–
Wang, L., Liu, Y., Du, T., Yang, H., Lei, L., Guo, M., Ding, H.-F., Zhang, J., Wang, H., Chen, X., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0380-z · Cited by 809
Sonodynamic therapy––a review of the synergistic effects of drugs and ultrasound
Rosenthal, I., Sostaric, J. Z., & Riesz, P. (2004) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2004.03.004 · Cited by 796
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
Smith, T. T., Stephan, S. B., Moffett, H. F., McKnight, L. E., Ji, W., Reiman, D., Bonagofski, E., Wohlfahrt, M. E., Pillai, S. P. S., & Stephan, M. T. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.57 · Cited by 785
Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy
Song, G., Cheng, L., Chao, Y., Yang, K., & Liu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201700996 · Cited by 771
Emerging Strategies of Cancer Therapy Based on Ferroptosis
Shen, Z., Song, J., Yung, B. C., Zhou, Z., Wu, A., & Chen, X. (2018) · Advanced Materials · doi:10.1002/adma.201704007 · Cited by 740
The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer
Kalinowski, D. S., & Richardson, D. R. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.2 · Cited by 721
Huang, P., Wang, D., Su, Y., Huang, W., Zhou, Y., Cui, D., Zhu, X., & Yan, D. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505212y · Cited by 716
Recent progress of chemodynamic therapy-induced combination cancer therapy
Wang, X., Zhong, X., Liu, Z., & Cheng, L. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100946 · Cited by 711
Piao, M. J., Kang, K. A., Lee, I. K., Kim, H. S., Kim, S., Choi, J. Y., Choi, J., & Hyun, J. W. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2010.12.010 · Cited by 701
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
Martin, J. D., Cabral, H., Stylianopoulos, T., & Jain, R. K. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0308-z · Cited by 682
Greco, F., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.006 · Cited by 652
Ma, P., Xiao, H., Yu, C., Liu, J., Cheng, Z., Song, H., Zhang, X., Li, C., Wang, J., Gu, Z., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04269 · Cited by 649
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Liu, C., Wang, D., Zhang, S., Cheng, Y., Yang, F., Xing, Y., Xu, T., Dong, H., & Zhang, X. (2019) · ACS Nano · doi:10.1021/acsnano.8b09387 · Cited by 641
Recent advances of cocktail chemotherapy by combination drug delivery systems
Hu, Q., Sun, W., Wang, C., & Gu, Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.022 · Cited by 625
Liu, Y., Zhen, W., Jin, L., Zhang, S., Sun, G., Zhang, T., Xu, X., Song, S., Wang, Y., Liu, J., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b01893 · Cited by 617
Gong, N., Ma, X., Ye, X., Zhou, Q., Chen, X., Tan, X., Yao, S., Huo, S., Zhang, T., Chen, S., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0373-6 · Cited by 601
Glutathione levels in human tumors
Gamcsik, M. P., Kasibhatla, M. S., Teeter, S. D., & Colvin, O. M. (2012) · Biomarkers · doi:10.3109/1354750x.2012.715672 · Cited by 600
Conrad, M., & Sato, H. (2012) · Amino Acids · doi:10.1007/s00726-011-0867-5 · Cited by 598
Dong, S., Dong, Y., Jia, T., Liu, S., Liu, J., Yang, D., He, F., Gai, S., Yang, P., & Lin, J. (2020) · Advanced Materials · doi:10.1002/adma.202002439 · Cited by 592
Sang, Y., Cao, F., Li, W., Zhang, L., You, Y., Deng, Q., Dong, K., Ren, J., & Qu, X. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b12873 · Cited by 591
Dixon, S. J., & Stockwell, B. R. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055844 · Cited by 577
The hallmarks of successful anticancer immunotherapy
Galluzzi, L., Chan, T. A., Kroemer, G., Wolchok, J. D., & López-Soto, A. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat7807 · Cited by 575
Fan, H., Yan, G., Zhao, Z., Hu, X., Zhang, W., Liu, H., Fu, X., Fu, T., Zhang, X., & Tan, W. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510748 · Cited by 567
The cancer–natural killer cell immunity cycle
Huntington, N. D., Cursons, J., & Rautela, J. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0272-z · Cited by 566
Shen, Y., Jin, E., Zhang, B., Murphy, C. J., Sui, M., Zhao, J., Wang, J., Tang, J., Fan, M., Van Kirk, E., et al. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909475m · Cited by 565
Cancer Treatment through Nanoparticle-Facilitated Fenton Reaction
Ranji-Burachaloo, H., Gurr, P. A., Dunstan, D. E., & Qiao, G. G. (2018) · ACS Nano · doi:10.1021/acsnano.8b07635 · Cited by 559
Sun, Y., Zheng, Y., Wang, C., & Liu, Y. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0794-4 · Cited by 545
GSH‐Depleted PtCu3 Nanocages for Chemodynamic‐ Enhanced Sonodynamic Cancer Therapy
Zhong, X., Wang, X., Cheng, L., Tang, Y., Zhan, G., Gong, F., Zhang, R., Hu, J., Liu, Z., & Yang, X. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201907954 · Cited by 541
Self-citationNanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review
Calixto, G., Bernegossi, J., De Freitas, L., Fontana, C., & Chorilli, M. (2016) · Molecules · doi:10.3390/molecules21030342 · Cited by 538
Cramer, S. L., Saha, A., Liu, J., Tadi, S., Tiziani, S., Yan, W., Triplett, K., Lamb, C., Alters, S. E., Rowlinson, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4232 · Cited by 538
Hamilton, T. C., Winker, M. A., Louie, K. G., Batist, G., Behrens, B. C., Tsuruo, T., Grotzinger, K. R., McKoy, W. M., Young, R. C., & Ozols, R. F. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90551-9 · Cited by 535
Gong, F., Cheng, L., Yang, N., Betzer, O., Feng, L., Zhou, Q., Li, Y., Chen, R., Popovtzer, R., & Liu, Z. (2019) · Advanced Materials · doi:10.1002/adma.201900730 · Cited by 533
Chinnaiyan, A. M., Prasad, U., Shankar, S., Hamstra, D. A., Shanaiah, M., Chenevert, T. L., Ross, B. D., & Rehemtulla, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030545097 · Cited by 530
Diamide, a new reagent for the intracellular oxidation of glutathione to the disulfide
Kosower, N. S., Kosower, E. M., Wertheim, B., & Correa, W. S. (1969) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(69)90850-x · Cited by 525
Glutathione primes t cell metabolism for inflammation
Mak, T. W., Grusdat, M., Duncan, G. S., Dostert, C., Nonnenmacher, Y., Cox, M., Binsfeld, C., Hao, Z., Brüstle, A., Itsumi, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.019 · Cited by 511
Glutathione metabolism as a determinant of therapeutic efficacy: a review.
Arrick, B. A., & Nathan, C. (1984) · PubMed · Cited by 506
Ju, E., Dong, K., Chen, Z., Liu, Z., Liu, C., Huang, Y., Wang, Z., Pu, F., Ren, J., & Qu, X. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201605509 · Cited by 506
Applications of patient-derived tumor xenograft models and tumor organoids
Yoshida, G. J. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0829-z · Cited by 471
Pike, L. S., Smift, A. L., Croteau, N. J., Ferrick, D. A., & Wu, M. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.022 · Cited by 469
Radioprotectors in Radiotherapy
NAIR, C. K. K., PARIDA, D. K., & NOMURA, T. (2001) · Journal of Radiation Research · doi:10.1269/jrr.42.21 · Cited by 466
Radiotherapy and Immunogenic Cell Death
Golden, E. B., & Apetoh, L. (2015) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2014.07.005 · Cited by 463
Noh, J., Kwon, B., Han, E., Park, M., Yang, W., Cho, W., Yoo, W., Khang, G., & Lee, D. (2015) · Nature Communications · doi:10.1038/ncomms7907 · Cited by 461
Advances in redox-responsive drug delivery systems of tumor microenvironment
Guo, X., Cheng, Y., Zhao, X., Luo, Y., Chen, J., & Yuan, W.-E. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0398-2 · Cited by 459
Duan, X., Chan, C., Guo, N., Han, W., Weichselbaum, R. R., & Lin, W. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b09538 · Cited by 458
Dong, Z., Feng, L., Chao, Y., Hao, Y., Chen, M., Gong, F., Han, X., Zhang, R., Cheng, L., & Liu, Z. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b03905 · Cited by 437
Switching Apoptosis to Ferroptosis: Metal–Organic Network for High-Efficiency Anticancer Therapy
Zheng, D.-W., Lei, Q., Zhu, J.-Y., Fan, J.-X., Li, C.-X., Li, C., Xu, Z., Cheng, S.-X., & Zhang, X.-Z. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04060 · Cited by 434
Song, G., Chen, Y., Liang, C., Yi, X., Liu, J., Sun, X., Shen, S., Yang, K., & Liu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201602111 · Cited by 394
Wang, S., Li, F., Qiao, R., Hu, X., Liao, H., Chen, L., Wu, J., Wu, H., Zhao, M., Liu, J., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b06399 · Cited by 381
Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives
Zhang, R. X., Wong, H. L., Xue, H. Y., Eoh, J. Y., & Wu, X. Y. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.012 · Cited by 380
Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
Yin, Q., Shen, J., Zhang, Z., Yu, H., & Li, Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.04.011 · Cited by 365
Chen, Z., Liu, L., Liang, R., Luo, Z., He, H., Wu, Z., Tian, H., Zheng, M., Ma, Y., & Cai, L. (2018) · ACS Nano · doi:10.1021/acsnano.8b04371 · Cited by 363
Yang, B., Ding, L., Yao, H., Chen, Y., & Shi, J. (2020) · Advanced Materials · doi:10.1002/adma.201907152 · Cited by 360
Ma, Y., Zhang, Y., Li, X., Zhao, Y., Li, M., Jiang, W., Tang, X., Dou, J., Lu, L., Wang, F., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b06040 · Cited by 355
Cellular mechanisms of multidrug resistance of tumor cells.
Stavrovskaya, A. A. (2000) · PubMed · Cited by 344
Meng, X., Deng, J., Liu, F., Guo, T., Liu, M., Dai, P., Fan, A., Wang, Z., & Zhao, Y. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02904 · Cited by 338
Liu, Y., Zhang, P., Li, F., Jin, X., Li, J., Chen, W., & Li, Q. (2018) · Theranostics · doi:10.7150/thno.22172 · Cited by 335
Dong, Z., Feng, L., Hao, Y., Li, Q., Chen, M., Yang, Z., Zhao, H., & Liu, Z. (2020) · Chem · doi:10.1016/j.chempr.2020.02.020 · Cited by 331
Zhang, W., Lu, J., Gao, X., Li, P., Zhang, W., Ma, Y., Wang, H., & Tang, B. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201710800 · Cited by 328
A Mn(III)-Sealed Metal–Organic Framework Nanosystem for Redox-Unlocked Tumor Theranostics
Wan, S.-S., Cheng, Q., Zeng, X., & Zhang, X.-Z. (2019) · ACS Nano · doi:10.1021/acsnano.9b00300 · Cited by 322
Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells
Ahamed, M., Akhtar, M. J., Siddiqui, M. A., Ahmad, J., Musarrat, J., Al-Khedhairy, A. A., AlSalhi, M. S., & Alrokayan, S. A. (2011) · Toxicology · doi:10.1016/j.tox.2011.02.010 · Cited by 319
Progress, challenges, and future of nanomedicine
Zhang, C., Yan, L., Wang, X., Zhu, S., Chen, C., Gu, Z., & Zhao, Y. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101008 · Cited by 318
Glutathione in Cancer Cell Death
Ortega, A. L., Mena, S., & Estrela, J. M. (2011) · Cancers · doi:10.3390/cancers3011285 · Cited by 317
Xu, T., Ma, Y., Yuan, Q., Hu, H., Hu, X., Qian, Z., Rolle, J. K., Gu, Y., & Li, S. (2020) · ACS Nano · doi:10.1021/acsnano.9b09426 · Cited by 316
Shih, A. Y., Erb, H., Sun, X., Toda, S., Kalivas, P. W., & Murphy, T. H. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3178-06.2006 · Cited by 315
Immunogenic effects of chemotherapy-induced tumor cell death
Wang, Y.-J., Fletcher, R., Yu, J., & Zhang, L. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.003 · Cited by 314
Molecular and nanoengineering approaches towards activatable cancer immunotherapy
Zhang, C., & Pu, K. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00773c · Cited by 302
Wang, S., Wang, Z., Yu, G., Zhou, Z., Jacobson, O., Liu, Y., Ma, Y., Zhang, F., Chen, Z., & Chen, X. (2019) · Advanced Science · doi:10.1002/advs.201801986 · Cited by 292
Drew, R., & Miners, J. O. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90598-7 · Cited by 291
Role of Glutathione in the Regulation of Cisplatin Resistance in Cancer Chemotherapy
Chen, H. H. W., & Kuo, M. T. (2010) · Metal-Based Drugs · doi:10.1155/2010/430939 · Cited by 287
Smart Design of Nanomaterials for Mitochondria‐Targeted Nanotherapeutics
Liew, S. S., Qin, X., Zhou, J., Li, L., Huang, W., & Yao, S. Q. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.201915826 · Cited by 286
Surface design of magnetic nanoparticles for stimuli-responsive cancer imaging and therapy
Kang, T., Li, F., Baik, S., Shao, W., Ling, D., & Hyeon, T. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.013 · Cited by 280
Yin, S., Song, G., Yang, Y., Zhao, Y., Wang, P., Zhu, L., Yin, X., & Zhang, X. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201901417 · Cited by 279
Rappa, G., Lorico, A., Flavell, R. A., & Sartorelli, A. C. (1997) · PubMed · Cited by 275
Xu, J., Shi, R., Chen, G., Dong, S., Yang, P., Zhang, Z., Niu, N., Gai, S., He, F., Fu, Y., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c00082 · Cited by 274
Bai, J., Jia, X., Zhen, W., Cheng, W., & Jiang, X. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b11114 · Cited by 272
Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
Wu, A. A., Drake, V., Huang, H.-S., Chiu, S., & Zheng, L. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1016700 · Cited by 271
Ding, H., Yu, H., Dong, Y., Tian, R., Huang, G., Boothman, D. A., Sumer, B. D., & Gao, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.019 · Cited by 271
Artificial Enzyme Catalyzed Cascade Reactions: Antitumor Immunotherapy Reinforced by NIR‐II Light
Wen, M., Ouyang, J., Wei, C., Li, H., Chen, W., & Liu, Y. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201909729 · Cited by 269
Burkitt, M. J. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2509 · Cited by 266
Calcium-based biomaterials for diagnosis, treatment, and theranostics
Qi, C., Lin, J., Fu, L.-H., & Huang, P. (2018) · Chemical Society Reviews · doi:10.1039/c6cs00746e · Cited by 265
Zhu, T., Shi, L., Yu, C., Dong, Y., Qiu, F., Shen, L., Qian, Q., Zhou, G., & Zhu, X. (2019) · Theranostics · doi:10.7150/thno.32867 · Cited by 264
Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy
Ling, X., Tu, J., Wang, J., Shajii, A., Kong, N., Feng, C., Zhang, Y., Yu, M., Xie, T., Bharwani, Z., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b06400 · Cited by 263
Brozovic, A., Ambriović-Ristov, A., & Osmak, M. (2010) · Critical Reviews in Toxicology · doi:10.3109/10408441003601836 · Cited by 261
Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species
Hagen, H., Marzenell, P., Jentzsch, E., Wenz, F., Veldwijk, M. R., & Mokhir, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2014937 · Cited by 260
Renes, J., De Vries, E. G. E., Nienhuis, E. F., Jansen, P. L. M., & Müller, M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702360 · Cited by 256
Cancer-Cell-Activated Photodynamic Therapy Assisted by Cu(II)-Based Metal–Organic Framework
Wang, Y., Wu, W., Liu, J., Manghnani, P. N., Hu, F., Ma, D., Teh, C., Wang, B., & Liu, B. (2019) · ACS Nano · doi:10.1021/acsnano.9b01665 · Cited by 248
Deng, Y., Jia, F., Chen, S., Shen, Z., Jin, Q., Fu, G., & Ji, J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.043 · Cited by 243
Yang, Y., Yu, Y., Chen, H., Meng, X., Ma, W., Yu, M., Li, Z., Li, C., Liu, H., Zhang, X., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c05541 · Cited by 240
Self-citationFu, J., Li, T., Zhu, Y., & Hao, Y. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201906195 · Cited by 238
Zhang, Y. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.175 · Cited by 234
Enhanced cancer therapy by hypoxia-responsive copper metal-organic frameworks nanosystem
Zhang, K., Meng, X., Yang, Z., Dong, H., & Zhang, X. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120278 · Cited by 232
Wang, T., Zhang, H., Liu, H., Yuan, Q., Ren, F., Han, Y., Sun, Q., Li, Z., & Gao, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201906128 · Cited by 229
Self-citationYong, Y., Zhang, C., Gu, Z., Du, J., Guo, Z., Dong, X., Xie, J., Zhang, G., Liu, X., & Zhao, Y. (2017) · ACS Nano · doi:10.1021/acsnano.7b03037 · Cited by 228
Dethmers, J. K., & Meister, A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7492 · Cited by 227
Engineering gold-based radiosensitizers for cancer radiotherapy
Goswami, N., Luo, Z., Yuan, X., Leong, D. T., & Xie, J. (2017) · Materials Horizons · doi:10.1039/c7mh00451f · Cited by 219
Li, J., Dirisala, A., Ge, Z., Wang, Y., Yin, W., Ke, W., Toh, K., Xie, J., Matsumoto, Y., Anraku, Y., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201706964 · Cited by 219
Triggered ferroptotic polymer micelles for reversing multidrug resistance to chemotherapy
Gao, M., Deng, J., Liu, F., Fan, A., Wang, Y., Wu, H., Ding, D., Kong, D., Wang, Z., Peer, D., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119486 · Cited by 218
Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
Meijer, C., Mulder, N. H., Timmer‐Bosscha, H., Sluiter, W. J., Meersma, G. J., & de Vries, E. G. E. (1992) · PubMed · Cited by 216
The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency
Liang, Q., Bie, N., Yong, T., Tang, K., Shi, X., Wei, Z., Jia, H., Zhang, X., Zhao, H., Huang, W., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0405-4 · Cited by 216
Self-citationMa, R., Ji, T., Zhang, H., Dong, W., Chen, X., Xu, P., Chen, D., Liang, X., Yin, X., Liu, Y., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-017-0002-2 · Cited by 211
Ling, X., Chen, X., Riddell, I. A., Tao, W., Wang, J., Hollett, G., Lippard, S. J., Farokhzad, O. C., Shi, J., & Wu, J. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01924 · Cited by 209
Yang, Y., Liu, X., Ma, W., Xu, Q., Chen, G., Wang, Y., Xiao, H., Li, N., Liang, X.-J., Yu, M., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120456 · Cited by 209
Versantvoort, C., Broxterman, H., Bagrij, T., Scheper, R., & Twentyman, P. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.281 · Cited by 207
Nanoparticles of biodegradable polymers for new-concept chemotherapy
Feng, S.-S. (2004) · Expert Review of Medical Devices · doi:10.1586/17434440.1.1.115 · Cited by 206
Ozols, R. F., Louie, K. G., Plowman, J., Behrens, B. C., Fine, R. L., Dykes, D., & Hamilton, T. C. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90392-3 · Cited by 202
GSH depletion liposome adjuvant for augmenting the photothermal immunotherapy of breast cancer
Zhou, Z., Wu, H., Yang, R., Xu, A., Zhang, Q., Dong, J., Qian, C., & Sun, M. (2020) · Science Advances · doi:10.1126/sciadv.abc4373 · Cited by 198
Redox Dyshomeostasis Strategy for Hypoxic Tumor Therapy Based on DNAzyme‐Loaded Electrophilic ZIFs
Li, Y., Zhao, P., Gong, T., Wang, H., Jiang, X., Cheng, H., Liu, Y., Wu, Y., & Bu, W. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202003653 · Cited by 197
Okuno, S., Sato, H., Kuriyama-Matsumura, K., Tamba, M., Wang, H., Sohda, S., Hamada, H., Yoshikawa, H., Kondo, T., & Bannai, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600786 · Cited by 191
Bailey, H. H., Mulcahy, R. T., Tutsch, K. D., Arzoomanian, R. Z., Alberti, D., Tombes, M. B., Wilding, G., Pomplun, M., & Spriggs, D. R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.194 · Cited by 188
Guo, X., Liu, F., Deng, J., Dai, P., Qin, Y., Li, Z., Wang, B., Fan, A., Wang, Z., & Zhao, Y. (2020) · ACS Nano · doi:10.1021/acsnano.0c00764 · Cited by 187
Self-citationXc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism
Ma, M.-Z., Chen, G., Wang, P., Lu, W.-H., Zhu, C.-F., Song, M., Yang, J., Wen, S., Xu, R.-H., Hu, Y., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.031 · Cited by 186
Maeda, H., Hori, S., Ohizumi, H., Segawa, T., Kakehi, Y., Ogawa, O., & Kakizuka, A. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401389 · Cited by 183
Mitochondrial Glutathione: Regulation and Functions
Calabrese, G., Morgan, B., & Riemer, J. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7121 · Cited by 182
Zhen, W., Liu, Y., Wang, W., Zhang, M., Hu, W., Jia, X., Wang, C., & Jiang, X. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201916142 · Cited by 181
Zhou, R., Wang, H., Yang, Y., Zhang, C., Dong, X., Du, J., Yan, L., Zhang, G., Gu, Z., & Zhao, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.016 · Cited by 178
Ma, S., Song, W., Xu, Y., Si, X., Lv, S., Zhang, Y., Tang, Z., & Chen, X. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b05265 · Cited by 178
Shen, W., Liu, W., Yang, H., Zhang, P., Xiao, C., & Chen, X. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.011 · Cited by 176
Self-citationSleire, L., Skeie, B. S., Netland, I. A., Førde, H. E., Dodoo, E., Selheim, F., Leiss, L., Heggdal, J. I., Pedersen, P.-H., Wang, J., et al. (2015) · Oncogene · doi:10.1038/onc.2015.60 · Cited by 175
Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.
Rudin, C. M., Yang, Z., Schumaker, L. M., VanderWeele, D. J., Newkirk, K. A., Egorin, M. J., Zuhowski, E. G., & Cullen, K. J. (2003) · PubMed · Cited by 174
Lu, Y., Yang, Y., Gu, Z., Zhang, J., Song, H., Xiang, G., & Yu, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.025 · Cited by 173
Tang, H., Chen, D., Li, C., Zheng, C., Wu, X., Zhang, Y., Song, Q., & Fei, W. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118782 · Cited by 173
Huo, D., Liu, S., Zhang, C., He, J., Zhou, Z., Zhang, H., & Hu, Y. (2017) · ACS Nano · doi:10.1021/acsnano.7b04737 · Cited by 172
A mitochondria-targeting magnetothermogenic nanozyme for magnet-induced synergistic cancer therapy
Shen, J., Rees, T. W., Zhou, Z., Yang, S., Ji, L., & Chao, H. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120079 · Cited by 172
Wang, C., Li, P., Liu, L., Pan, H., Li, H., Cai, L., & Ma, Y. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.040 · Cited by 170
Suzuki, S. W., Onodera, J., & Ohsumi, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017412 · Cited by 168
You, B. R., & Park, W. H. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.04.009 · Cited by 166
Ji, X., Kang, Y., Ouyang, J., Chen, Y., Artzi, D., Zeng, X., Xiao, Y., Feng, C., Qi, B., Kim, N. Y., et al. (2019) · Advanced Science · doi:10.1002/advs.201901211 · Cited by 165
Rocha, C. R. R., Garcia, C. C. M., Vieira, D. B., Quinet, A., de Andrade-Lima, L. C., Munford, V, Belizário, J. E., & Menck, C. F. M. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.465 · Cited by 164
Phase I Study of Continuous-Infusion L-S,R-Buthionine Sulfoximine With Intravenous Melphalan
Bailey, H. H., Ripple, G., Tutsch, K. D., Arzoomanian, R. Z., Alberti, D., Feierabend, C., Mahvi, D., Schink, J., Pomplun, M., Mulcahy, R. T., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1789 · Cited by 164
Radiosensitization by gold nanoparticles: Will they ever make it to the clinic?
Cui, L., Her, S., Borst, G. R., Bristow, R. G., Jaffray, D. A., & Allen, C. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.007 · Cited by 164
Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.
O'Dwyer, P. J., Hamilton, T. C., LaCreta, F. P., Gallo, J. M., Kilpatrick, D., Halbherr, T., Brennan, J., Bookman, M. A., Hoffman, J., Young, R. C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.249 · Cited by 162
Redox Responsive Metal Organic Framework Nanoparticles Induces Ferroptosis for Cancer Therapy
He, H., Du, L., Guo, H., An, Y., Lu, L., Chen, Y., Wang, Y., Zhong, H., Shen, J., Wu, J., et al. (2020) · Small · doi:10.1002/smll.202001251 · Cited by 162
Hulsman, N., Medema, J. P., Bos, C. L., Jongejan, A., Leurs, R., Smit, M. J., de Esch, I. J. P., Richel, D. J., & Wijtmans, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061371e · Cited by 157
Nanomedicine and macroscale materials in immuno-oncology
Sun, Q., Barz, M., Geest, B. G. D., Diken, M., Hennink, W. E., Kiessling, F. M., Lammers, T., & Shi, Y. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00473k · Cited by 157
Subramanian, A. P., Jaganathan, S. K., Manikandan, A., Pandiaraj, K. N., Gomathi, N., & Supriyanto, E. (2016) · RSC Advances · doi:10.1039/c6ra07802h · Cited by 156
Zhu, J. X., Chu, C., Li, D., Pang, X., Zheng, H., Wang, J., Shi, Y., Zhang, Y., Cheng, Y., Ren, E., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201904056 · Cited by 156
Chen, Q., Zhou, J., Chen, Z., Luo, Q., Xu, J., & Song, G. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b09323 · Cited by 154
Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates
Zhang, Y. (2001) · Carcinogenesis · doi:10.1093/carcin/22.3.425 · Cited by 151
Xu, Y., Han, X., Li, Y., Min, H., Zhao, X., Zhang, Y., Qi, Y., Shi, J. Y., Qi, S., Bao, Y., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b07032 · Cited by 149
Shi, Y., Zhang, J., Huang, H., Cao, C., Yin, J., Xu, W., Wang, W., Song, X., Zhang, Y., & Dong, X. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000005 · Cited by 149
Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy
Zhang, C., Yan, L., Gu, Z., & Zhao, Y. (2019) · Chemical Science · doi:10.1039/c9sc02107h · Cited by 147
Guan, X., Yin, H., Xu, X. N., Xu, G., Zhang, Y., Zhou, B., Yue, W., Liu, C., Sun, L., Xu, H., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000326 · Cited by 146
Cited by
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 890
2D Piezoelectric Bi2MoO6 Nanoribbons for GSH‐Enhanced Sonodynamic Therapy
Dong, Y., Dong, S., Liu, B., Yu, C., Liu, J., Yang, D., Yang, P., & Lin, J. (2021) · Advanced Materials · doi:10.1002/adma.202106838 · Cited by 337
Yao, L., Zhao, M.-M., Luo, Q.-W., Zhang, Y.-C., Liu, T.-T., Yang, Z., Liao, M., Tu, P., & Zeng, K.-W. (2022) · ACS Nano · doi:10.1021/acsnano.2c01619 · Cited by 289
Strategies for enhancing cancer chemodynamic therapy performance
Jana, D., & Zhao, Y. (2022) · Exploration · doi:10.1002/exp.20210238 · Cited by 284
Xu, W., Qian, J., Hou, G., Wang, T., Wang, J., Wang, Y., Yang, L., Cui, X., & Suo, A. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202205013 · Cited by 267
Metadata
- Authors
- Xiong, Y., Xiao, C., Li, Z., & Yang, X.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2021
- Volume
- 50
- Issue
- 10
- Pages
- 6013-6041
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W3152019175
- Cited by
- 692
- References
- 272
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.